Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comparison of Carmustine-, Lomustine-, and Nitrosourea-free Conditioning Regimens for Autologous Hematopoietic Cell Transplantation in Lymphoma (auto-HTC): Results from the Hematopoietic Cell Transplantation Brazilian Registry (HCTBR).

Transplantation and cellular therapy·2026

Same author

Haploidentical Versus HLA-matched Unrelated Donors for Hematopoietic Cell Transplantation in Acute Leukemia: A Multicenter Observational Study in a Developing Country Facilitated by Collaboration Between the CIBMTR and the Brazilian Society of Cellular Therapy and Bone Marrow Transplantation (SBTMO).

Transplantation and cellular therapy·2026

Same author

Oral manifestations and dental management in patients undergoing CAR-T cell therapy: a retrospective observational study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

Same author

Patients with myelodysplastic/myeloproliferative neoplasms have higher rates of relapse following allogeneic hematopoietic cell transplantation compared to those with MDS: A Brazilian SBTMO/CIBMTR registry analysis.

Bone marrow transplantation·2026

Same author

Improving Chimeric Antigen Receptor T Access in Latin America: Promises, Barriers, and a Call to Action.

JCO global oncology·2026

Same author

Outcomes of Allogeneic Hematopoietic Cell Transplantation for Hypoplastic Myelodysplastic Syndrome: A Latin American Multicenter Analysis.

Transplantation and cellular therapy·2026

Search research articles

Related Experiment Video

Updated: Jun 29, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

Leukemia: genetics and prognostic factors.

Nelson Hamerschlak¹

¹Programa de Hematologia e Unidade de Transplantes de Medula Ossea, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil. hamer@einstein.br

Jornal De Pediatria

|December 4, 2008

Summary

This summary is machine-generated.

Genetic testing, including cytogenetic techniques, is crucial for diagnosing and predicting leukemia outcomes. Understanding genetic mutations aids in personalized treatment strategies for various leukemia types, improving patient prognosis.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Related Experiment Videos

Last Updated: Jun 29, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Area of Science:

Hematology
Oncology
Genetics

Background:

Cytogenetic techniques have revolutionized leukemia diagnosis and prognosis.
The discovery of the Philadelphia chromosome (9:22 translocation) marked a significant advancement in understanding chronic myeloid leukemia.

Purpose of the Study:

To explore the implications of genetic findings, particularly cytogenetic techniques, in the diagnosis and prognosis of leukemia.
To highlight the role of genetics in guiding treatment decisions and predicting patient outcomes.

Main Methods:

A comprehensive literature review was conducted.
Articles were selected from reputable sources including MEDLINE, American Society of Hematology educational programs, CAPES web portal, National Comprehensive Cancer Network, and textbook chapters.

Main Results:

Genetic factors are pivotal in diagnosing chronic myeloid leukemia and offer insights into oncology research.
Karyotype analysis is essential for postremission treatment decisions in acute myeloid leukemia, while molecular factors guide treatment for normal karyotypes.
Clonal evolution in chronic myeloid leukemia correlates with blast crisis progression, and ABL gene mutations can cause imatinib resistance.
Specific genetic markers like hyperdiploidy and t(12;21) in acute lymphoblastic leukemia indicate a good prognosis, whereas t(4;11) and t(9;22) are associated with high-risk disease.

Conclusions:

Genetics is indispensable in hematology for leukemia management and prognostic assessment.
Integrating genetic testing results into treatment planning is vital for achieving optimal patient outcomes.